Silver nanoparticles: synthesis, properties, and therapeutic applications

•AgNPs possess intrinsic therapeutic properties for biomedical applications.•AgNPs are employed in newly emerging applications as photosensitizers/radiosensitizers, antiviral and anticancer agents.•Treatment of a variety of cancers with AgNPs has been documented with AgNPs.•The underlying anticancer...

Full description

Saved in:
Bibliographic Details
Published inDrug discovery today Vol. 20; no. 5; pp. 595 - 601
Main Authors Wei, Liuya, Lu, Jingran, Xu, Huizhong, Patel, Atish, Chen, Zhe-Sheng, Chen, Guofang
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•AgNPs possess intrinsic therapeutic properties for biomedical applications.•AgNPs are employed in newly emerging applications as photosensitizers/radiosensitizers, antiviral and anticancer agents.•Treatment of a variety of cancers with AgNPs has been documented with AgNPs.•The underlying anticancer mechanisms of AgNPs include (1) disruption of cell membranes, and (2) production of reactive oxygen species and Ag+ to damage protein or DNA.•The photosensitizing mechanism of AgNPs is based on nonradiative decay converting photo energy to thermal energy. Silver nanoparticles (AgNPs) have been widely used in biomedical fields because of their intrinsic therapeutic properties. Here, we introduce methods of synthesizing AgNPs and discuss their physicochemical, localized surface plasmon resonance (LSPR) and toxicity properties. We also review the impact of AgNPs on human health and the environment along with the underlying mechanisms. More importantly, we highlight the newly emerging applications of AgNPs as antiviral agents, photosensitizers and/or radiosensitizers, and anticancer therapeutic agents in the treatment of leukemia, breast cancer, hepatocellular carcinoma, lung cancer, and skin and/or oral carcinoma.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Current address: Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
ISSN:1359-6446
1878-5832
DOI:10.1016/j.drudis.2014.11.014